Acquisition of a transposon encoding extended-spectrum β-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3956-3959

  Uemura, Shuji ^a   Yokota, Shin Ichi ^a   Mizuno, Hirotoshi ^a   Sakawaki, Eiji ^a   Sawamoto, Keigo ^a   Maekawa, Kunihiko ^a   Tanno, Katsutoshi ^a   Mori, Kazuhisa ^a   Asai, Yasufumi ^a   Fujii, Nobuhiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; BETA LACTAMASE SHV; EXTENDED SPECTRUM BETA LACTAMASE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN; BURN PATIENT; CASE REPORT; CHROMOSOME; FEMALE; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRANSPOSON;

ADULT; BETA-LACTAMASES; BURNS; DNA TRANSPOSABLE ELEMENTS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA;

EID: 77956101404     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00110-10     Document Type: Article

References (22)

1. Brasme, L., P. Nordmann, F. Fidel, M. F. Lartigue, O. Bajolet, L. Poirel, D. Forte, V. Vernet-Garnier, J. Madoux, J. C. Reveil, C. Alba-Sauviat, I. Baudinat, P. Bineau, C. Bouquigny-Saison, C. Eloy, C. Lafaurie, D. Simeon, J. P. Verquin, F. Noel, C. Strady, and C. De Champs. 2007. Incidence of class A extended-spectrum β-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J. Antimicrob. Chemother. 60:956-964.
2. Chanawong, A., F. H. M'Zali, J. Heritage, A. Lulitanond, and P. M. Hawkey. 2001. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother. 48:839-852.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M07-7. Wayne, PA.
4. Dubois, V., C. Arpin, V. Dupart, A. Scavelli, L. Coulange, C. Andre, I. Fischer, F. Grobost, J. P. Brochet, I. Lagrange, B. Dutilh, J. Jullin, P. Noury, G. Larribet, and C. Quentin. 2008. β-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J. Antimicrob. Chemother. 62:316-323.
5. Hawkey, P. M. 2008. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl. 1):159-165.
6. Homma, J. Y. 1982. Designation of the thirteen O-group antigens of Pseudomonas aeruginosa; an amendment for the tentative proposal in 1976. Jpn. J. Exp. Med. 52:317-320.
7. SHV-2a in Korea. J. Antimicrob. Chemother. 49:261-267.
8. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
9. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
10. Mansour, W., S. Dahmen, L. Poirel, K. Charfi, D. Bettaieb, N. Boujaafar, and O. Bouallegue. 2009. Emergence of SHV-2a extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa in a university hospital in Tunisia. Microb. Drug Resist. 15:295-301.
11. Naas, T., L. Philippon, L. Poirel, E. Ronco, and P. Nordmann. 1999. An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1281-1284.
12. Neonakis, I. K., E. V. Scoulica, S. K. Dimitriou, A. I. Gikas, and Y. J. Tselentis. 2003. Molecular epidemiology of extended-spectrum β-lactamases produced by clinical isolates in a university hospital in Greece: detection of SHV-5 in Pseudomonas aeruginosa and prevalence of SHV-12. Microb. Drug Resist. 9:161-165.
13. Oh, S. J., S. U. Lee, H. Y. Hwang, I. K. Bae, H. S. Jo, B. H. Lee, and S. H. Jeong. 2006. Prevalence of class A extended-spectrum β-lactamases in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa. Korean J. Lab. Med. 26:14-20.
14. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
15. Poirel, L., E. Lebessi, M. Castro, C. Fevre, M. Foustoukou, and P. Nordmann. 2004. Nosocomial outbreak of extended-spectrum β-lactamase SHV- 5-producing isolates of Pseudomonas aeruginosa in Athens, Greece. Antimicrob. Agents Chemother. 48:2277-2279.
16. Poole, K. 2005. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:479-487.
17. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
18. Shahcheraghi, F., V. S. Nikbin, and M. M. Feizabadi. 2009. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb. Drug Resist. 15:37-39.
19. Weldhagen, G. F., L. Poirel, and P. Nordmann. 2003. Ambler class A extended- spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob. Agents Chemother. 47:2385-2392.
20. Yagi, T., H. Kurokawa, N. Shibata, K. Shibayama, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184:53-56.
21. Yamano, Y., T. Nishikawa, T. Fujimura, T. Yutsudou, M. Tsuji, and H. Miwa. 2006. Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem. J. Antibiot. (Tokyo) 59:791-796.
22. Yamasaki, K., M. Komatsu, T. Yamashita, K. Shimakawa, T. Ura, H. Nishio, K. Satoh, R. Washidu, S. Kinoshita, and M. Aihara. 2003. Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J. Antimicrob. Chemother. 51:631-638.